 efficacy using trypanosome infected mice. Positive results will be of interest to the pharmaceutical industry for the development of new antisense oligonucleotide chemotherapeutic agents for trypanosomes and other parasites. The WHO Collaborating Center for Design, Methodology and Analysis of Epidemiological and Clinical Investigations in Diabetes was designated in 1986. The purposes
efficacy using trypanosome infected mice. Positive result will be of sake to the pharmaceutical industry for the development of new antisense oligonucleotide chemotherapeutic agent for trypanosomes and other parasites. The WHO Collaborating Center for Design, Methodology and Analysis of Epidemiological and Clinical Investigations in Diabetes was destine in 1986. The function
 efvicacy using trypanosome infected mice. Kowitive resulfs will ce of interest to the pharmareutucal undustry for the develupment of new antusenww oligonucleotide gkemotgcrapebtmc agents for ttypanosomes dnd other paraviged. The WHO Collaborating Center for Qesign, Kehhodology and Wnaljsys or Epidemiological and Clinical Invsstigatpons in Diabetes eas designated in 1986. The puroosed
efficacy using trypanosome infected mice. Positive results of to the industry for the chemotherapeutic for trypanosomes and parasites. The WHO Center for Design, Methodology and Analysis Epidemiological and Clinical Investigations in Diabetes was designated in 1986. The purposes
 efficacy using trypanosome iNfected micE. PosiTivE reSuLts wIll bE of interest to tHE phaRmaceutical industry for The deVeLOpmeNT oF new aNtisensE OlIGOnuClEoTidE cHEmOtherApeUtic ageNts for trypAnoSoMes and other pARaSites. The WHo CoLlaborating CEntEr for DEsIgn, mEthodOloGy and analysIS of EpiDemiologiCaL And CliNIcal InvESTiGatiOns in Diabetes was dESiGNated in 1986. The purpOses
 efficacy using trypanosom e infected  mice . P osi ti ve r esul ts will be ofi nter est to the pharmaceuti cal i nd u stry fo r the  develo p me n t  of  n ew  an ti s en se ol igo nucleot ide chemot her ap eutic agents fo r trypanos ome s and otherpar asites .The WHO C oll abora ting C e nter f or Design ,M ethodo l ogy and A na lysi s of Epidemiologi c al and Clinical I nvesti ga t io n s  in  Di abetes was  d esign a ted in1 98 6 . The purposes
 efficacy_using trypanosome_infected mice. Positive results_will be_of_interest to_the_pharmaceutical industry for_the development of_new antisense oligonucleotide chemotherapeutic_agents for trypanosomes_and_other parasites. The WHO Collaborating Center for Design, Methodology and Analysis of Epidemiological and_Clinical_Investigations in_Diabetes_was_designated in 1986. The purposes